INTU
58
-3
DNB
74
-6
IPG
34
-9
NEE
54
7
TMO
42
-6
AZO
50
-5
K
51
-3
CPB
22
-5
MTB
65
-2
ADM
28
3
RIG
43
-7
FOXA
52
-14
RL
69
-4
ETN
75
-3
PEG
62
4
FRT
41
-2
SPG
60
2
PCAR
56
-5
SNA
70
-5
DOV
65
-4
INTU
58
-3
DNB
74
-6
IPG
34
-9
NEE
54
7
TMO
42
-6
AZO
50
-5
K
51
-3
CPB
22
-5
MTB
65
-2
ADM
28
3
RIG
43
-7
FOXA
52
-14
RL
69
-4
ETN
75
-3
PEG
62
4
FRT
41
-2
SPG
60
2
PCAR
56
-5
SNA
70
-5
DOV
65
-4
Financhill
Back

First Trust Structured CrdOpp ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
11

SCIO
First Trust Structured CrdOpp ETF

Last Price:
20.35
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
11
First Trust Structured CrdOpp ETF (SCIO) is a Sell

Is First Trust Structured CrdOpp ETF a Buy, Sell or Hold?

  • The current First Trust Structured CrdOpp ETF [SCIO] share price is $20.32. The Score for SCIO is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
  • SCIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCIO Stock Price Chart

What is First Trust Structured CrdOpp ETF's stock price today?

  • The First Trust Structured CrdOpp ETF share price today is $20.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SCIO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SCIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 40.51 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.28 - 20.44) Sell
Bollinger Bands (100): (20.29 - 20.55) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SCIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 20.33 Sell
20-day SMA: 20.32 Sell
50-day SMA: 20.47 Sell
200-day SMA: 0 Buy
8-day EMA: 20.33 Sell
20-day EMA: 20.35 Sell
50-day EMA: 20.4 Sell
200-day EMA: 12.84 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

First Trust Structured CrdOpp ETF Earnings Growth & SCIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

First Trust Structured CrdOpp ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):